WithdrawnPhase 3NCT00916656

Fibrinogen Concentrate (Human) - Efficacy and Safety Study

Studying Congenital fibrinogen deficiency

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: CSL Behring
Principal Investigator: Program Director, Clinical R&D
CSL Behring
Intervention: Fibrinogen Concentrate, Human (FCH)(biological)
Eligibility: All sexes
Timeline: 2009 – 2014

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00916656 on ClinicalTrials.gov

Other trials for Congenital fibrinogen deficiency

Additional recruiting or active studies for the same condition.

RECRUITINGNCT07097337
Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department
Erasmus Medical Center

See all trials for Congenital fibrinogen deficiency →

← Back to all trials